Two human breast carcinoma cell lines, MCF7 without expression of ErbB2 and BT474 overexpressing ErbB2, were employed to evaluate the role of EC1-GLuc-p53C in specific bioluminescence imaging and cancer therapy. Here, ERBB2 is linked to cancer.